Rongtong Dictionary · Formula

Xuefu Zhuyu Decoction: Wang Qingren's 'Blood Mansion' Theory, the Blood-Moving Qi-Regulating Logic, the Five Zhuyu Formulas, and Modern Evidence

Published and reviewed 2026-07-09

Xuefu Zhuyu (Blood Mansion Stasis-Expelling) Decoction comes from the Qing physician Wang Qingren's Yilin Gaicuo and is the representative formula for 'invigorate blood and dispel stasis, move qi and relieve pain' — the first of the 'five zhuyu formulas' and often called the 'first formula for invigorating blood and dispelling stasis.' Wang devised it from his 'blood mansion' theory (that blood pooling below the diaphragm forms a 'mansion' where stasis can arise), building it from Taohong Siwu Decoction combined with Sini San plus platycodon and achyranthes for the 'chest blood-stasis pattern.' It is both a model of 'pairing blood-moving with qi-moving, joining stasis-dispelling with blood-nourishing, and tending both ascent and descent,' and — because it contains many blood-invigorating herbs with bleeding and anticoagulant-interaction risk — a case where a 'blood-stasis pattern' is not a modern diagnosis of coronary or cerebrovascular disease and must be professionally managed.

Origin: Wang Qingren and the 'blood mansion' theory

Xuefu Zhuyu Decoction comes from the Qing physician Wang Qingren (1768-1831) and his Yilin Gaicuo (Correcting the Errors of Medicine). Wang emphasized anatomy and insisted that 'treating disease requires understanding the organs'; he held that a pool of blood collects in the low space below the diaphragm, which he named the 'blood mansion,' and from the inference that 'the blood mansion can generate stasis' he created this formula. The Yilin Gaicuo states plainly: 'establishing Xuefu Zhuyu Decoction to treat the chest blood-mansion stasis pattern.' It is the most representative of Wang's blood-invigorating formulas and is later called the 'first formula for invigorating blood and dispelling stasis.'

Structurally, the formula is a fusion of two classics: Taohong Siwu Decoction (Siwu with peach kernel and safflower, substituting raw rehmannia for prepared and red peony for white) combined with Sini San (substituting bitter orange for immature bitter orange), plus platycodon and achyranthes. The former 'invigorates and nourishes blood,' the latter 'moves qi and courses the liver,' and together they embody the principle that 'when qi moves, blood moves.' Note: Wang's 'blood mansion' is a theoretical construct based on the anatomy of his time and does not correspond to modern anatomical concepts. This page identifies the entity only and offers no dose conversion or preparation procedure.

Composition: blood-moving, qi-moving, and ascent-descent in parallel

Eleven ingredients: peach kernel (Persicae Semen, sovereign), safflower (Carthami Flos, sovereign), red peony (Paeoniae Radix Rubra, minister), chuanxiong (Chuanxiong Rhizoma, minister), achyranthes (Achyranthis Bidentatae Radix, minister), angelica (Angelicae Sinensis Radix, assistant), raw rehmannia (Rehmanniae Radix, assistant), platycodon (Platycodonis Radix, assistant-envoy), bitter orange (Aurantii Fructus, assistant), bupleurum (Bupleuri Radix, assistant), and licorice (Glycyrrhizae Radix, envoy).

In the textbook reading, peach kernel breaks blood and moves stagnation while moistening, and safflower invigorates blood and dispels stasis to relieve pain, together sovereign; red peony and chuanxiong aid them in invigorating blood, and achyranthes invigorates the channels and directs blood downward, together ministers; raw rehmannia and angelica nourish blood and yin and clear heat, platycodon and bitter orange raise and descend to loosen the chest and move qi, and bupleurum courses the liver and raises clear yang (with platycodon and bitter orange especially good at regulating qi so that moving qi moves blood), all assistants; platycodon also carries the drugs upward as envoy, and licorice harmonizes as envoy. The formula has three compatibility features: pairing blood-moving with qi-moving (both dispersing blood stasis and resolving qi constraint); joining stasis-dispelling with blood-nourishing (invigorating without consuming blood, dispelling stasis while generating the new); and tending both ascent and descent. Together, blood is invigorated, stasis dissolved, and qi moved, so the pattern resolves.

Pattern, not disease: 'chest blood stasis' is not coronary or cerebrovascular disease

The textbook mechanism is 'chest blood stasis with qi-dynamic constraint and stasis transforming into heat over time.' The chest is where qi is mustered, blood gathers, and the liver channel passes; blood stasis there constrains the qi dynamic and blocks clear yang, so chest pain and headache persist, 'stabbing and fixed in place' (stabbing pain, fixed location, and chronicity being typical of blood stasis); stasis becoming heat brings inner vexing heat and evening tidal fever; stasis-heat harassing the heart brings palpitations and insomnia; the liver failing to course brings irritability; and dark lips, dark eyes, a dark-red tongue with stasis spots, and a choppy or wiry-tight pulse are all signs of stasis. The method is 'invigorate blood, dispel stasis, and additionally move qi to relieve pain.'

Here 'blood mansion,' 'blood stasis,' and 'chest' are traditional functional constructs. Although the textbook notes the formula is 'now commonly used for coronary heart disease angina, cerebral thrombosis, and hypertension' belonging to stasis-obstruction-with-qi-stagnation, a 'blood-stasis pattern' is emphatically not a synonym for coronary heart disease, myocardial infarction, cerebral thrombosis, post-concussion syndrome, or any modern diagnosis — the qualifier 'belonging to stasis-obstruction with qi stagnation' is crucial. Chest pain especially demands caution: acute coronary syndrome and the like are lethal emergencies requiring immediate medical care, absolutely not a matter for self-administered 'blood-invigoration.' Similar symptoms do not imply the same pattern, still less that the formula may replace emergency and standard treatment.

Historical development: the five zhuyu-formula lineage

The formula's stature comes from its role as the representative and pivot of Wang's 'zhuyu' series. For blood stasis in different locations, Wang created a set of 'zhuyu decoctions,' later collectively called the five zhuyu formulas, all sharing peach kernel, safflower, chuanxiong, red peony, and angelica as the blood-invigorating base but each with its own emphasis: Xuefu Zhuyu adds bitter orange, platycodon, bupleurum, and achyranthes, excelling at freeing chest-and-flank qi stagnation and directing blood downward, for chest stasis; Tongqiao Huoxue adds musk and scallion to free yang and open the orifices, for stasis of the head and face; Gexia Zhuyu adds cyperus and lindera to course the liver and move qi, for sub-diaphragmatic (abdominal) stasis with liver-qi stagnation; Shaofu Zhuyu adds fennel, cinnamon, and dried ginger to warm the channels, for lower-abdominal stasis and dysmenorrhea; and Shentong Zhuyu adds gentiana, notopterygium, and earthworm to free the network vessels, for generalized pain from stasis obstructing the channels.

This set, with 'one blood-invigorating core plus different channel-guiding and qi-moving herbs by location,' systematically unfolds the 'invigorate blood, dispel stasis' method — an outstanding example of the 'differentiate by location and concurrent pattern' idea. Wang's blood-stasis doctrine deeply influenced later ages, and modern 'blood-stasis pattern and blood-invigorating research' became an important field of integrated medicine. Understanding the distinctions among the five zhuyu formulas is the key to why 'the same stasis calls for different formulas,' and it reminds readers not to conflate the five, nor to generalize Xuefu Zhuyu into a cure-all for every 'stasis.'

Active constituents: exploration of blood-rheology and microcirculation

In modern terms, the material basis involves the actives of many blood-invigorating herbs: peach kernel's amygdalin, safflower's hydroxysafflor yellow A (HSYA), chuanxiong's tetramethylpyrazine and ferulic acid, red peony's paeoniflorin, and angelica's ferulic acid. Pharmacology reports that the formula improves blood rheology and microcirculation, dilates vessels, and increases blood flow to ischemic organs, with animal experiments suggesting it lessens myocardial ischemia and shrinks the ischemic/infarct area. Network-pharmacology and metabolomics studies (such as an analysis of 241 components and multiple targets) attempt to sketch a 'multi-component, multi-target' stasis-improving mechanism hypothesis.

The caveat: these are largely in-vitro, animal, and computational — mechanistic exploration. More importantly, the 'improve blood rheology, antiplatelet/anticoagulant' pharmacology is double-edged — it is part of the material basis of the 'invigorate blood' experience and also corresponds directly to the bleeding and anticoagulant-interaction risk below. A mechanistic 'blood-invigoration' must never be equated with proven efficacy in human disease, still less used to overlook the potential bleeding risk.

Evidence: what coronary-heart-disease-angina research shows

The formula has considerable research in coronary heart disease angina. A systematic review and meta-analysis (PMID 34630621) found that the decoction alone and combined with chemical drugs had overall clinical effectiveness about 1.13 times (RR 1.13, 95% CI 1.03-1.24) and 1.26 times (RR 1.26, 95% CI 1.20-1.32) that of chemical drugs, respectively; it also suggested shortened angina duration, improved vascular endothelial function, and lowered pattern scores, with lipid-regulation benefit when combined. A systematic review of RCTs also exists for the patent medicine 'Xuefu Zhuyu capsule' in unstable angina.

How to state it? First, the most robust signal appears in 'combined with chemical drugs versus chemical drugs alone' — an adjunctive/combination role, which cannot be extrapolated to 'replacing standard coronary-disease treatment.' Second, included studies are mostly Chinese-language with variable methodological quality and risk of bias, and heterogeneity needs attention. Third, 'overall effectiveness' is a composite outcome, not improvement of hard endpoints such as myocardial infarction or death. The defensible statement is that, as combination therapy, it showed a signal of improving outcomes such as angina symptoms, with limited evidence quality needing high-quality RCT confirmation — not that it is proven to treat coronary heart disease or can replace Western drugs. Standard coronary-disease care must be led by cardiology.

Quality standards, patent medicines, and the Western-drug context

Peach kernel, safflower, red peony, chuanxiong, achyranthes, angelica, raw rehmannia, platycodon, bitter orange, bupleurum, and licorice are all Chinese Pharmacopoeia (2020) materials (safflower by hydroxysafflor yellow A, chuanxiong by ferulic acid). The market offers Xuefu Zhuyu oral liquid, capsule, and pill; same-named forms may differ in ratio and process, and selection still requires differentiation.

As contextual overlap (relationship only, not an efficacy comparison): the formula's modern research settings (coronary angina, cerebrovascular disease) correspond at the Western-drug level to categories such as antiplatelet drugs (aspirin, clopidogrel), anticoagulants (warfarin), anti-anginal drugs, and lipid regulators — and this 'adjacency' points precisely to the most important safety issue: the formula's many blood-invigorating herbs have antiplatelet/coagulation-affecting tendencies, so combining with the above antiplatelet or anticoagulant drugs may stack and raise bleeding risk. This is a statement of relationship, not efficacy comparison, but for exactly that reason combination must be rigorously assessed by professionals and never self-layered.

Safety boundaries: bleeding risk and pregnancy contraindication

Xuefu Zhuyu is a vigorous blood-invigorating, stasis-dispelling formula whose boundaries must be stressed. First, bleeding tendency and anticoagulant interaction: peach kernel, safflower, chuanxiong, red peony, and angelica largely invigorate blood and affect coagulation, so those with a bleeding tendency, heavy menstrual flow, or in the perioperative period, and those taking antiplatelet/anticoagulant drugs such as aspirin, clopidogrel, or warfarin, may face significantly raised bleeding risk on combination, which must be professionally assessed. Second, contraindicated in pregnancy: blood-invigorating herbs risk stirring blood and disturbing the fetus, so pregnant and pregnancy-planning women should not use it or use it with caution.

Third, the red line of use: chest pain may signal a lethal emergency such as acute coronary syndrome, so persistent or severe chest pain, tightness and breathlessness, profuse sweating, or radiating pain require immediate medical care and emergency services, never self-administered 'blood-invigoration' or delay. Judging a blood-stasis pattern and using blood-invigorating formulas belongs to professional differentiation, and the standard care of coronary and cerebrovascular disease must be left to specialists. Xuefu Zhuyu is an excellent model for the wisdom of 'invigorate blood, move qi,' but its stasis-expelling power also means corresponding risk.

A checklist for reading any formula article

1. Composition and preparation: does a stated effect come from Xuefu Zhuyu itself, or from Tongqiao/Gexia/Shaofu/Shentong Zhuyu or a patent medicine like Xuefu Zhuyu capsule? The five zhuyu formulas must not be conflated.
2. Pattern versus disease: has 'chest blood stasis' been equated directly with coronary heart disease, myocardial infarction, or cerebral thrombosis, and has the qualifier 'belonging to stasis-obstruction with qi stagnation' been dropped?
3. Evidence tier and scenario: is the positive result 'monotherapy' or 'combined with Western drugs,' and the outcome a composite like 'overall effectiveness' or a hard endpoint — with what quality and heterogeneity?
4. Safety and interactions: does it stress bleeding risk, interaction with antiplatelet/anticoagulant drugs, pregnancy contraindication, and that chest pain demands emergency care?
5. Dose and procedure: responsible education identifies the entity and stops short of individual dosing and modifications — prescriptions require a qualified physician and pharmacist.

Educational and academic reference only. It does not provide a diagnosis, prescription, dosage, or treatment recommendation. This is a vigorous blood-invigorating formula, contraindicated in pregnancy, and combining it with antiplatelet/anticoagulant drugs may raise bleeding risk. Chest pain may signal a lethal emergency such as acute coronary syndrome — seek immediate medical care and emergency services; consult a licensed physician and pharmacist for any prescription.